Back
Gitlab, Inc. Vs. Novartis AG Industry Stock Comparison
Sell
21
GTLB
Gitlab, Inc.
Last Price:
$38.42
Seasonality Move:
-20.64%
Buy
71
NVSEF
Novartis AG
Last Price:
$130.78
Seasonality Move:
-4.44%
Sell
21
Gitlab, Inc. (GTLB)
is a Sell
Is Gitlab, Inc. a Buy, Sell or Hold?
-
The current Gitlab, Inc. [GTLB] share price is $38.10. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $138.80. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GTLB Stock Price Chart
What is Gitlab, Inc.'s stock price today?
-
The Gitlab, Inc. share price today is $38.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight buying pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $138.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
GTLB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.61 | Sell |
| Relative Strength Index (14 RSI): | 37.68 | Sell |
| Chaikin Money Flow: | 260233 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.73 - 43.87) | Sell |
| Bollinger Bands (100): | (41.62 - 48.48) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 69.21 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GTLB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.11 | Sell |
| 20-day SMA: | 40.44 | Sell |
| 50-day SMA: | 44.14 | Sell |
| 200-day SMA: | 46.05 | Sell |
| 8-day EMA: | 39.22 | Sell |
| 20-day EMA: | 40.59 | Sell |
| 50-day EMA: | 42.99 | Sell |
| 200-day EMA: | 46.97 | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.44 | Buy |
| 20-day SMA: | 127.9 | Buy |
| 50-day SMA: | 128.04 | Buy |
| 200-day SMA: | 119.05 | Buy |
| 8-day EMA: | 129.81 | Buy |
| 20-day EMA: | 128.39 | Buy |
| 50-day EMA: | 127.3 | Buy |
| 200-day EMA: | 120.27 | Buy |
Gitlab, Inc. Earnings Growth & GTLB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Gitlab, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||